Remove 2013 Remove Compliance Remove Medicare Remove US Department of Health and Human Services
article thumbnail

Florida Home Health Company Pays $2.1M to Resolve False Claims Allegations

Healthcare Compliance Blog

A home health services company headquartered in Kentucky, and its related entities, paid $2.1 million to the United States government to settle claims of improperly billing the Medicare Program for home health services provided to beneficiaries living in Florida.

article thumbnail

Oklahoma Hospital Pays over $1.1 Million to Settle False Claims Act Allegations

Healthcare Compliance Blog

million to settle allegations that it violated the False Claims Act by submitting false claims to Medicare. Following an internal review and audit, the hospital discovered irregularities regarding its billing of certain services, and proactively contacted the United States to self-disclose the issues.?The to resolve the claims.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Home Health Company to Pay $22.9M to Settle Federal False Claims Act and Kickback Allegations

Med-Net Compliance

The settlement resolves allegations that between 2013 and 2020, the company paid remuneration to its home health medical directors in Oklahoma and Texas for the purpose of inducing referrals of Medicare and TRICARE home health patients. The corporate officers were previously the CEO and COO of the company.

article thumbnail

CMS Advances Rulemaking for Section 111 Civil Money Penalties and Future Medicals

Medval Compliance Blog

by Frank Fairchok, Vice President of Medicare Reporting Services. Last week, the Centers for Medicare & Medicaid Services (CMS) advanced the rulemaking process in two long-awaited areas. 0938-AT85 – Medicare Secondary Payer and Future Medicals (CMS-6047).

article thumbnail

Fifth Circuit Upholds ACA Risk Adjustment Program

Healthcare Law Blog

Various smaller health insurance issuers have challenged the risk-adjustment program under the Patient Protection and Affordable Care Act (ACA), alleging, among other things, that its underlying methodology favors larger insurers. See Vista Health Plan, Inc. United States Dep’t of Health & Hum. The Risk-Adjustment Program.

ACA 52
article thumbnail

The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023

Drug & Device Law

Executive Health Resources, Inc. , Executive Health Resources, Inc. , 2023) (rejecting any express anti-preemption presumption in Medicare case) ( here ); Baker v. United States Department of Health and Human Services , 58 F.4th In 2023, these include United States ex rel. Polansky v. 3d 239 (Cal.

FDA 105